Xynomic Pharmaceuticals Picks up Second Cancer Drug From Boehringer Ingelheim in $800 Million Deal Life Science
Gan & Lee and a Leading Pharmaceutical Company Enters into Global Collaboration to Commercialize Insulin Analog Life Science
Chi-Med Announces Amendment to the 2013 License & Collaboration Agreement on Fruquintinib with Eli Lilly and Company Life Science
RBC Capital Markets to start doing deals for cannabis companies, but will be ‘selective’ Cannabis, Life Science
Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis Life Science